Latest news
US FDA to hold advisory meeting to review Grail's multi-cancer test - ReutersReuters · Fri, 07 Aug 2026 18:51:34 GMTNRx Pharma rises on FDA review of ketamine ANDA (NRXP:NASDAQ) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 17:08:38 GMTA vial used in products that shipped 11.9M doses remains in NRx's FDA review - Stock TitanStock Titan · Fri, 07 Aug 2026 11:00:00 GMTModerna’s mRNA flu shot earns FDA approval after rollercoaster review - Ars TechnicaArs Technica · Thu, 06 Aug 2026 16:31:06 GMTFDA's Overhaul of Food Ingredient Safety Review Clears the White House, Setting Up a Rule Decades in the Making - Medical DailyMedical Daily · Thu, 06 Aug 2026 14:30:07 GMTFDA Approves First mRNA Flu Vaccine in Win for Moderna After Arduous Review - WSJWSJ · Thu, 06 Aug 2026 14:01:00 GMTFDA Approves Moderna's mRNA Flu Vaccine After Initially Refusing To Review It - EngadgetEngadget · Thu, 06 Aug 2026 08:52:16 GMTModerna's mRNA flu shot mFlusiva snags FDA nod after refusal-to-file imbroglio - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 03:36:50 GMT